Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to 0.2%.

  • LifeStance Health's EBITDA Margin rose 27000.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.72%, marking a year-over-year increase of 74800.0%. This contributed to the annual value of 4.7% for FY2024, which is 130300.0% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's EBITDA Margin is 0.2%, which was up 27000.0% from 1.18% recorded in Q2 2025.
  • LifeStance Health's 5-year EBITDA Margin high stood at 0.2% for Q3 2025, and its period low was 69.29% during Q3 2021.
  • Over the past 5 years, LifeStance Health's median EBITDA Margin value was 15.93% (recorded in 2022), while the average stood at 19.28%.
  • As far as peak fluctuations go, LifeStance Health's EBITDA Margin plummeted by -660600bps in 2021, and later skyrocketed by 533600bps in 2022.
  • LifeStance Health's EBITDA Margin (Quarter) stood at 56.86% in 2021, then soared by 64bps to 20.3% in 2022, then grew by 17bps to 16.76% in 2023, then soared by 87bps to 2.14% in 2024, then soared by 109bps to 0.2% in 2025.
  • Its last three reported values are 0.2% in Q3 2025, 1.18% for Q2 2025, and 0.12% during Q1 2025.